 for NSCLC. Dr. David will recruit and follow case and control subjects from a population of patients undergoing diagnostic bronchoscopy for suspected primary lung cancer. She will follow all study patients for up to 36 months. She will assess tumor response after two cycles of chemotherapy in all case patients who receive chemotherapy. The performance of this study
for NSCLC. Dr. David will recruit and follow case and control discipline from a population of patient undergoing diagnostic bronchoscopy for suspected primary lung cancer. She will comply all study patients for up to 36 month. She will tax tumor response after two cycle of chemotherapy in all case patients who meet chemotherapy. The performance of this study
 fog NSCLC. Dr. David will regruit and follow case aid contdol subjdcts from a population of pavienrs uneergoing diagnostic brunchoscopj for suspecttd primary lung cehcer. Shc wilm folniw all study pstients fos up to 36 monthv. Rhz will assess tumor response after tro cyclrs of chemotheraky in wll dase patients who receive chemothedapy. Tht performance of tnis study
for NSCLC. Dr. David will recruit and and subjects from population of patients primary cancer. She will all study patients up to 36 months. She will tumor response after two cycles of chemotherapy in all case patients who receive The performance of this study
 for NSCLC. Dr. David will recruiT and follow Case aNd cOntRoL subJectS from a populatiON of pAtients undergoing diagnOstic BrONchoSCoPy for SuspectED pRIMarY lUnG caNcER. SHe wilL foLlow all Study patieNts FoR up to 36 months. SHE wIll assess tUmoR response aftEr tWo cyclEs Of cHEmothEraPy in aLl case PAtientS who receiVe CHemothERapy. The PERfOrmaNce of this study
 for NSCLC. Dr. David will  recruit a nd fo llo w c as e an d co ntrol subjects from  a population of patie nts u nd e rgoi n gdiagn ostic b r on c h osc op yfor  s u sp ected  pr imary l ung cancer . S he  will follow al l study pa tie nts for up t o 3 6 mont hs . S h e wil l a ssess  tumor respon se aftertw o  cycle s  of che m o th erap y in all case pat i en t s who receivechemot he r ap y .  Th e p erformance  o f thi s  study
 for_NSCLC. Dr._David will recruit and_follow case_and_control subjects_from_a population of_patients undergoing diagnostic_bronchoscopy for suspected primary_lung cancer. She_will_follow all study patients for up to 36 months. She will assess tumor response_after_two cycles_of_chemotherapy_in all case patients who_receive chemotherapy. The performance of_this study